Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

Bull and Bear

Top Analyst Upgrades and Downgrades: ARIAD, FedEx, Genpact, Suncor, Travelers, UPS and More

Stocks were trying to post a recovery on Thursday morning on the heels of three days worth of energy-related selling. Despite a relatively harsh drop, investors have proven over and ...
Read Full Story »
ten bucks

Ten Analyst Stocks to Buy Under $10 for Big Upside

Earnings season is winding down and the markets remain choppy. Investors are wary, but they want upside and they keep hearing that this is now a stock picker's market. 24/7 ...
Read Full Story »
buy sell

Six Unusual Hot Stocks on the Move Monday Morning

Stocks are indicated lower on Monday, with the S&P 500 futures down seven points at 1,867.50 and DJIA futures down 61 points around 16,386. Investors and traders alike are still ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Ariad, Chipotle, Disney, FireEye, L-3, SINA and More

Stocks are still within striking distance of new highs, yet the Dow is barely changed for the year. Earnings season is underway, and investors are careful in their attempts to ...
Read Full Story »
rumors

Ariad Joins Rumor Mill: Hope May Trump Reality

Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) is joining the ranks of the next big biotech acquisitions. At least so goes the rumor mill. Ariad fits the bill of many biotech acquirers ...
Read Full Story »
Monkey evil

Top Analyst Downgrades, Stocks to Sell: Apple, Twitter, First Solar and More

It is the first full trading week of 2014, and investors are trying to decide how to position their portfolios for the year. Wall Street brokerage firms are making their ...
Read Full Story »
Monkey evil

Top Analyst Upgrades and Downgrades: BlackBerry, Five Below, Micron, Tiffany and More

Stocks are challenging new highs going into Christmas and year-end, and investors have to be positioning their portfolios for 2014 and beyond. 24/7 Wall St. reviews many Wall Street analyst ...
Read Full Story »
2014 in the box

Cowen Forecasts Top 10 Potential Biotech Surprises for 2014

All of the major firms on Wall Street we cover have prognostications and stock picks for 2014. The Cowen biotechnology team has a list of top 10 surprises that are ...
Read Full Story »
investing

Nuance and ARIAD Are Volume Movers for Very Different Reasons

Nearly 39 million shares of Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) have traded hands as of 11:30 a.m. Tuesday morning, nearly triple the stock's average daily volume of around 14 million ...
Read Full Story »
Pills

Shire, Novartis Deals: Pharmaceutical Shakeups Continue

The wave of mergers and acquisitions in health care continues with two big announcements Monday. Drug maker Shire PLC (NASDAQ: SHPG) will acquire the rare disease biopharmaceutical company ViroPharma (NASDAQ: ...
Read Full Story »
170622870

Ariad Going to Hell in a Handbasket

Things just keep getting worse for Ariad Pharmaceuticals Inc. (NASDAQ: ARIA). In fact, a series of shareholder revolts are probably in the works here after yet another massive drop on ...
Read Full Story »
Bull and Bear

Top Analyst Downgrades, Stocks to Sell: Ariad, Goodyear, Myriad, Kellogg and More

Stocks are at all-time highs now that a deal has been reached in Washington, D.C., and investors have to wonder which stocks are set to keep rising and which ones ...
Read Full Story »
biotech

pSivida, Alimera and Ariad Join Bio-Implosion Watch

Biotech and emerging health care technology companies both fit into a high-stake poker match on Wall Street. Investors can earn exponential rewards if they are right, or they can lose ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Ariad, Hecla, HP, Micron and More

Earnings season has officially started, but the stock market and bond market are both dealing with the government shutdown, an upcoming debt ceiling and even the announcement of a new ...
Read Full Story »
Food and Drug Administration logo

FDA Hold on Ariad Kills $2 Billion in Value (Updated)

Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) is getting crushed on Wednesday due to a clinical hold placed by the U.S. Food & Drug Administration. The company confirmed that the FDA has ...
Read Full Story »